Trial
NCT04104321
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
Phase IIISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Galmed Research and Development, Ltd.
Collaborators
—
Condition
Nonalcoholic Steatohepatitis (NASH)
Intervention
Aramchol free acid
Why stopped
Interim analysis results from the open-label part of the study. The double blind portion of the study will be resumed once the study will continue.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-11